TORONTO--(BUSINESS WIRE)--Axela Inc., a recognized innovator in protein interaction technology, announced today it has expanded its Board of Directors as the company positions itself for growth in the diagnostic, life science, and pharmaceutical research markets. Joining Axela’s board are Dave Lemus, David Giddings, and Bill Clarke, MD.
